Japanese Journal of Ophthalmology

Papers
(The H4-Index of Japanese Journal of Ophthalmology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Two-year outcomes of anterior versus posterior scleral application of mitomycin C-soaked sponge in trabeculectomy75
Short-term efficacy and safety of PreserFlo MicroShunt in Japanese patients with medically treated primary open-angle glaucoma37
Effects of trabeculectomy on the postoperative central visual field as revealed by refraction values34
2021 trends in the treatment of patients with strabismus in Japan33
Choroidal circulation time by wide-field indocyanine green angiography in central serous chorioretinopathy33
The optimal cut-off value of non-cycloplegic autorefraction for diagnosing myopia in school-aged children33
Two-year treatment outcomes after anti-vascular endothelial growth factor therapy in age-related macular degeneration with type 2 macular neovascularization in Japanese patients32
Comparison of one-year postoperative outcomes between PreserFlo MicroShunt and trabeculectomy in Japanese patients with open angle glaucoma: a retrospective cohort study using propensity score matchin26
Hypertensive phase after a novel small-lumen non-valved drainage device: predictive factors and two-year outcomes23
Involvement of best-corrected visual acuity in sarcopenia: findings from baseline analysis of the Kyotango longevity cohort study23
Displacement of the retina and changes in the foveal avascular zone area after internal limiting membrane peeling for epiretinal membrane21
Three-year efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma21
Temporal changes in parameters associated with tear film stability after instillation of long-acting diquafosol ophthalmic solution in soft contact lens wearers20
Comparison of intraocular pressure elevation following intravitreal injection of 70 µl aflibercept 8 mg19
Usage status of biologics for the chronic treatment of optic neuritis in neuromyelitis optica spectrum disorders in Japan18
Paired-eye comparison of photocoagulation versus intravitreal bevacizumab for retinopathy of prematurity: long-term visual, refractive, and ocular biometric outcomes at corrected ages 1, 5, and 9 year17
Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration16
Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in Japan16
0.09606409072876